|1|Positive impact of chronic graft-versus-host disease on the outcome of patients with de novo myelodysplastic syndrome after allogeneic hematopoietic cell transplantation: a single-center analysis of 115 patients. (24127668)
Hiramoto N.... Fukuda T.
|2|Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease. (23242592)
Chakraborty R.... Dotti G.
|3|Limited benefit of pentostatin salvage therapy for steroid-refractory grade III-IV acute graft-versus-host disease. (24304375)
Alam N.... Kuruvilla J.
|4|Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. (23480177)
Turpeinen H.... Partanen J.
|5|Isomorphic sclerotic-type cutaneous chronic graft-versus-host disease: report and review of chronic graft-versus-host disease in a cutaneous immunocompromised district. (24318412)
|6|Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis. (23871780)
Kanakry J.A.... Ambinder R.F.
|7|Inducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target. (23694952)
Sato M.... Graves S.S.
|8|Successful response to infliximab of recurrent pericardial graft versus host disease in a pediatric patient. (22580769)
Rubio P.M.... Sastre A.
|9|The use of novel Therakosa8c CellexAr for extracorporeal photopheresis in treatment of graft-versus-host disease in paediatric patients. (23961954)
Rangarajan H.G.... Talano J.A.
|10|Mesenchymal stromal cells treatment attenuates dry eye in patients with chronic graft-versus-host disease. (23070118)
Weng J.... Du X.
|11|Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of I+-defensins. (22535662)
Eriguchi Y.... Teshima T.
|12|Erythema ab igne as a differential diagnosis of chronic graft versus host disease (GVHD). (22834457)
Blumetti T.P.... Fernandez-PeA+as P.
|13|Oral cGVHD screening tests in the diagnosis of systemic chronic graft-versus-host disease. (21369795)
Resende R.G.... Abreu M.H.
|14|Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. (22371885)
Chaidos A.... Karadimitris A.
|15|Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosis. (19786111)
Snyder D.S.... Forman S.J.
|16|Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases. (20514533)
Lim J.H.... Song S.U.
|17|Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease. (19857590)
Patel K.J.... Barker J.N.
|18|Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors. (20042727)
Penack O.... van den Brink M.R.
|19|HBs seroconversion in a patient with acute hepatitis B treated with entecavir during immunosuppression against severe bronchiolitis obliterans in the course of chronic graft versus host disease. (20403727)
Christopeit M.... Behre G.
|20|Possible role of engraftment syndrome and autologous graft-versus-host disease in myelodysplastic syndrome after autologous stem cell transplantations: retrospective analysis and review of the literature. (20371446)
Keung Y.K.... Hurd D.D.
|21|Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. (19925878)
Zhou H.... Zhao R.C.
|22|A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease. (20217287)
Onishi C.... Sakamaki H.
|23|Pathogenetic role of tissue factor in endothelial-injury in graft-versus-host disease]. (19954621)
Li Q.... Zou P.
|24|Acute graft-versus-host disease: from the bench to the bedside. (19713461)
SociAc G.... Blazar B.R.
|25|Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis. (19896085)
Yagasaki H.... Kodera Y.
|26|Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study. (19589490)
Remberger M.... Sundberg B.
|27|Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. (19508292)
Mahindra A.... Copelan E.
|28|Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. (18209723)
Elmaagacli A.H.... Beelen D.W.
|29|Vascular endothelial growth factor gene polymorphisms may predict the risk of acute graft-versus-host disease following allogeneic transplantation: preventive effect of vascular endothelial growth factor gene on acute graft-versus-host disease. (19041064)
Kim D.H.... Sohn S.K.
|30|U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. (18241274)
Scarisbrick J.J.... Marshall S.
|31|Third party mesenchymal stromal cell infusions fail to induce tissue repair despite successful control of severe grade IV acute graft-versus-host disease in a child with juvenile myelo-monocytic leukemia. (17972946)
Ball L.... Egeler M.
|32|Absence of cutaneous TNFalpha-producing CD4+ T cells and TNFalpha may allow for fibrosis rather than epithelial cytotoxicity in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. (17429441)
Askew D.... Gilliam A.C.
|33|Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity. (17318079)
Ilan Y.... Nagler A.
|34|Phase II study of pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease. (17878478)
Jacobsohn D.A.... Vogelsang G.B.
|35|Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis - was Demodex the culprit? (16474408)
Lotze C.... DAPlken G.
|36|Diagnosis and treatment of chronic graft-versus-host disease. (16412791)
Gilman A.L.... Serody J.
|37|A case of severe sclerodermatous chronic graft-versus-host disease: exposure to cement containing abundant silica may have been a relevant factor in scleroderma-like skin changes. (16043910)
Uenishi T.... Sugiura H.
|38|Regulation of OX40 gene expression in graft-versus-host disease. (15808546)
Miura Y.... Hess A.D.
|39|Protective conditioning for acute graft-versus-host disease. (16192477)
Lowsky R.... Strober S.
|40|Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease. (15744237)
Shaughnessy P.J.... Lemaistre C.F.
|41|Intestinal cryptosporidiosis mimicking acute graft-versus-host disease following matched unrelated hematopoietic stem cell transplantation. (15167618)
MA1ller C.I.... Kreisel W.
|42|Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand. (14993881)
Miura Y.... Hess A.D.
|43|TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms. (12734353)
Brown G.R.... Thiele D.L.
|44|Roles of interleukin-10 in acute graft-versus-host disease and graft rejection. (12875717)
Ju X.... LA1 S.
|45|The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. (10779417)
Hill G.R.... Ferrara J.L.
|46|Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. (10887333)
Nakamura H.... Masaoka T.
|47|Anti-mitosin antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation. (9156273)
Muro Y.... Hagiwara M.
|48|Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. (8640164)
Miyamoto T.... Niho Y.
|49|Antigenaemia during acute graft versus host disease. (7745106)
Fegan C.... Whittaker J.A.
|50|Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor. (8049447)
Anasetti C.... Storb R.